Drug-induced interstitial lung disease: Indictment for apixaban

被引：0
|
作者：
Capron, Thibaut [1 ]
Botto, Guillaume [1 ]
Roujon, Jean-Jacques [1 ]
Miltgen, Jean [1 ]
Berard, Henri [1 ]
机构：
[1] Elsan Polyclin Fleurs, Cabinet Pneumol, Ollioules, France
来源：
RESPIRATORY MEDICINE AND RESEARCH | 2023年 / 84卷
关键词：
Drug-induced interstitial lung disease; Apixaban; Direct oral anticoagulants; Adverse event;
D O I：
10.1016/j.resmer.2023.101024
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Successful treatment with crizotinib after alectinib-induced interstitial lung disease
    Zhu, Ning
    Lin, Shanhong
    He, Lei
    Wang, Linfeng
    Kong, Weiliang
    Cao, Chao
    SAGE OPEN MEDICAL CASE REPORTS, 2021, 9
  • [42] Successful treatment with alectinib after crizotinib-induced interstitial lung disease
    Chino, Haruka
    Sekine, Akimasa
    Kitamura, Hideya
    Kato, Terufumi
    Ogura, Takashi
    LUNG CANCER, 2015, 90 (03) : 610 - 613
  • [43] The Histopathology of Abemaciclib-Induced Interstitial Lung Disease: A First Case Report With Transbronchial Lung Cryobiopsy
    Kaburaki, Shota
    Tanaka, Toru
    Murata, Akari
    Kamio, Koichiro
    Tanaka, Yosuke
    Terasaki, Yasuhiro
    Kasahara, Kazuo
    Seike, Masahiro
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2024, 18
  • [44] Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17
    Yamane, Hiromichi
    Ochi, Nobuaki
    Nagasaki, Yasunari
    Yamagishi, Tomoko
    Honda, Yoshihiro
    Nakagawa, Nozomu
    Takeyama, Masami
    Nakanishi, Hidekazu
    Takigawa, Nagio
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1457 - 1465
  • [45] Drug-induced thrombocytopenia after anticoagulation with rivaroxaban
    Pop, Marianne K.
    Farokhi, Farhad
    Iduna, Lela
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2018, 36 (03) : 531.e1 - 531.e2
  • [46] Interstitial lung disease induced by alectinib (CH5424802/RO5424802)
    Ikeda, Satoshi
    Yoshioka, Hiroshige
    Arita, Machiko
    Sakai, Takahiro
    Sone, Naoyuki
    Nishiyama, Akihiro
    Niwa, Takashi
    Hotta, Machiko
    Tanaka, Tomohiro
    Ishida, Tadashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (02) : 221 - 224
  • [47] Two Cases and a Review of the Literature Regarding Severe Interstitial Lung Disease Induced by Hangeshashinto
    Kosugi, Yasuo
    Murakami, Naoya
    Muramoto, Yoichi
    Karino, Tatsuki
    Oshima, Masaki
    Kawamoto, Terufumi
    Motomura, Hiroaki
    Nakazawa, Shun
    Koinuma, Yoshika
    Ohba, Shinichi
    Matsumoto, Fumihiko
    Shikama, Naoto
    INTERNAL MEDICINE, 2025, 64 (06) : 905 - 910
  • [48] Drug Repurposing Prediction and Validation From Clinical Big Data for the Effective Treatment of Interstitial Lung Disease
    Siswanto, Soni
    Yamamoto, Hiroki
    Furuta, Haruka
    Kobayashi, Mone
    Nagashima, Takuya
    Kayanuma, Gen
    Nagayasu, Kazuki
    Imai, Yumiko
    Kaneko, Shuji
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease
    Villgran, V. D.
    Rabold, E.
    Nasrullah, A.
    Disilvio, B.
    Bajwa, O.
    RESPIRATORY MEDICINE CASE REPORTS, 2021, 33
  • [50] Successful Treatment with Ramucirumab Plus Erlotinib following Osimertinib-induced Interstitial Lung Disease
    Fujimoto, Shodai
    Katsurada, Naoko
    Hazama, Daisuke
    Yamamoto, Masatsugu
    Nagano, Tatusya
    Tachihara, Motoko
    INTERNAL MEDICINE, 2025, 64 (05) : 749 - 751
12345